Foresite Capital Management VI LLC
Source: SEC Form 13F · as of Mar 2026Foresite Capital Management VI LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $323.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$323.6M
| Company | Shares | Value |
|---|---|---|
| CGONCG Oncology, Inc. | 2,221,474 | $150.3M |
| CNTACentessa Pharmaceuticals plc | 1,364,019 | $54.2M |
| CRVSCorvus Pharmaceuticals, Inc. | 1,831,233 | $26.8M |
| DNLIDenali Therapeutics Inc. | 1,209,971 | $23.2M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 525,000 | $17.8M |
| KYMRKymera Therapeutics, Inc. | 146,332 | $12.2M |
| CLDXCelldex Therapeutics, Inc. | 315,913 | $10.0M |
| ATAIAtai Beckley N.V. | 2,750,000 | $9.7M |
| CRNXCrinetics Pharmaceuticals, Inc. | 212,010 | $7.7M |
| JBIOJade Biosciences, Inc. | 320,000 | $4.5M |
| GHRSGH Research PLC | 315,492 | $4.4M |
| ZURAZura Bio Ltd | 450,000 | $2.7M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.